Investigational Drug Details
Drug ID: | D449 |
Drug Name: | Semaglutide + (Cilofexor or/and Firsocostat) |
Synonyms: | -- |
Type: | Combinatory |
DrugBank ID: | -- |
DrugBank Description: | -- |
PubChem ID: | -- |
CasNo: | -- |
Repositioning for NAFLD: | No |
SMILES: | -- |
InChiKey: | -- |
Molecular Weight: | -- |
DrugBank Targets: | -- |
DrugBank MoA: | -- |
DrugBank Pharmacology: | -- |
DrugBank Indication: | -- |
Targets: | GLP1 receptor agonist & FXR agonist & ACC inhibitor |
Therapeutic Category: | -- |
Clinical Trial Progress: | Phase 2 on-going (NCT04971785) |
Latest Progress: | Under clinical trials |

Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted |
---|
Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name | |
---|---|---|---|---|---|---|---|
T17 | Farnesoid X-activated receptor | NR1H4 | agonist | Nuclear hormone receptor | Q96RI1 | NR1H4_HUMAN | Details |
T18 | Acetyl-CoA carboxylase 1 | ACACA | inhibitor | Enzyme | Q13085 | ACACA_HUMAN | Details |
T07 | Bile acid receptor | NR1H4 | agonist | Nuclear hormone receptor | Q96RI1 | NR1H4_HUMAN | Details |
Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
---|
Article ID | PMID | Source | Title |
---|